These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11131655

  • 1. Hyaluronidase-induced periodic modulation of the interstitial fluid pressure increases selective antibody uptake in human osteosarcoma xenografts.
    Brekken C, Hjelstuen MH, Bruland ØS, de Lange Davies C.
    Anticancer Res; 2000; 20(5B):3513-9. PubMed ID: 11131655
    [Abstract] [Full Text] [Related]

  • 2. Interstitial fluid pressure in human osteosarcoma xenografts: significance of implantation site and the response to intratumoral injection of hyaluronidase.
    Brekken C, Bruland ØS, de Lange Davies C.
    Anticancer Res; 2000; 20(5B):3503-12. PubMed ID: 11131654
    [Abstract] [Full Text] [Related]

  • 3. Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts.
    Eikenes L, Bruland ØS, Brekken C, Davies Cde L.
    Cancer Res; 2004 Jul 15; 64(14):4768-73. PubMed ID: 15256445
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of internally labeled monoclonal antibodies as a gold standard: comparison of biodistribution of 75Se-, 111In-, and 125I-labeled monoclonal antibodies in osteogenic sarcoma xenografts in nude mice.
    Koizumi M, Endo K, Watanabe Y, Saga T, Sakahara H, Konishi J, Yamamuro T, Toyama S.
    Cancer Res; 1989 Apr 01; 49(7):1752-7. PubMed ID: 2924318
    [Abstract] [Full Text] [Related]

  • 5. Rapid and specific targeting of 125I-labeled B lymphocyte stimulator to lymphoid tissues and B cell tumors in mice.
    Riccobene TA, Miceli RC, Lincoln C, Knight Y, Meadows J, Stabin MG, Sung C.
    J Nucl Med; 2003 Mar 01; 44(3):422-33. PubMed ID: 12621010
    [Abstract] [Full Text] [Related]

  • 6. Preparation and preclinical assessment of folate-conjugated, radiolabelled antibodies.
    Henriksen G, Bruland OS, Larsen RH.
    Anticancer Res; 2005 Mar 01; 25(1A):9-15. PubMed ID: 15816513
    [Abstract] [Full Text] [Related]

  • 7. Localization of GD2-specific monoclonal antibody 3F8 in human osteosarcoma.
    Heiner JP, Miraldi F, Kallick S, Makley J, Neely J, Smith-Mensah WH, Cheung NK.
    Cancer Res; 1987 Oct 15; 47(20):5377-81. PubMed ID: 3115567
    [Abstract] [Full Text] [Related]

  • 8. Radioiodination via D-amino acid peptide enhances cellular retention and tumor xenograft targeting of an internalizing anti-epidermal growth factor receptor variant III monoclonal antibody.
    Foulon CF, Reist CJ, Bigner DD, Zalutsky MR.
    Cancer Res; 2000 Aug 15; 60(16):4453-60. PubMed ID: 10969792
    [Abstract] [Full Text] [Related]

  • 9. Radiolocalization of xenografted human lung cancer with monoclonal antibody 8 in nude mice.
    Endo K, Kamma H, Ogata T.
    Cancer Res; 1987 Oct 15; 47(20):5427-32. PubMed ID: 3652045
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of monoclonal antibody uptake in human colon tumor xenografts following irradiation.
    Kalofonos H, Rowlinson G, Epenetos AA.
    Cancer Res; 1990 Jan 01; 50(1):159-63. PubMed ID: 2403414
    [Abstract] [Full Text] [Related]

  • 11. Uptake and distribution of specific and control monoclonal antibodies in subcutaneous xenografts following intratumor injection.
    Rowlinson-Busza G, Bamias A, Krausz T, Epenetos AA.
    Cancer Res; 1991 Jun 15; 51(12):3251-6. PubMed ID: 2040000
    [Abstract] [Full Text] [Related]

  • 12. Improved biodistribution of 125I-labeled anti-Tac disulfide-stabilized Fv fragment by blocking its binding to the alpha subunit of the interleukin 2 receptor in the circulation with preinjected humanized anti-Tac IgG.
    Kobayashi H, Yoo TM, Drumm D, Kim MK, Sun BF, Le N, Webber KO, Pastan I, Waldmann TA, Paik CH, Carrasquillo JA.
    Cancer Res; 1997 May 15; 57(10):1955-61. PubMed ID: 9157991
    [Abstract] [Full Text] [Related]

  • 13. Relationship between in vitro binding activity and in vivo tumor accumulation of radiolabeled monoclonal antibodies.
    Sakahara H, Endo K, Koizumi M, Nakashima T, Kunimatsu M, Watanabe Y, Kawamura Y, Nakamura T, Tanaka H, Kotoura Y.
    J Nucl Med; 1988 Feb 15; 29(2):235-40. PubMed ID: 3162255
    [Abstract] [Full Text] [Related]

  • 14. Comparison of 125I- and (111)In-labeled monoclonal antibody BR96 for tumor targeting in combination with extracorporeal immunoadsorption.
    Garkavij M, Tennvall J, Ohlsson T, Lindgren L, Hindorf C, Sjögren HO, Strand SE.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3059s-3064s. PubMed ID: 10541344
    [Abstract] [Full Text] [Related]

  • 15. Mechanisms of heterogeneous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure.
    Jain RK, Baxter LT.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7022-32. PubMed ID: 3191477
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
    Murray JL, Zukiwski AA, Mujoo K, Rosenblum MG.
    J Biol Response Mod; 1990 Dec 15; 9(6):556-63. PubMed ID: 2074442
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tissue distribution of poly(hexyl 2-cyanoacrylate) nanoparticles coated with monoclonal antibodies in mice bearing human tumor xenografts.
    Illum L, Jones PD, Baldwin RW, Davis SS.
    J Pharmacol Exp Ther; 1984 Sep 15; 230(3):733-6. PubMed ID: 6590835
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.